These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 24409954)

  • 1. Personalized drug discovery: HCA approach optimized for rare diseases at Tel Aviv University.
    Solmesky LJ; Weil M
    Comb Chem High Throughput Screen; 2014 Mar; 17(3):253-5. PubMed ID: 24409954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-content drug screening for rare diseases.
    Bellomo F; Medina DL; De Leo E; Panarella A; Emma F
    J Inherit Metab Dis; 2017 Jul; 40(4):601-607. PubMed ID: 28593466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. UCSF Small Molecule Discovery Center: innovation, collaboration and chemical biology in the Bay Area.
    Arkin MR; Ang KK; Chen S; Davies J; Merron C; Tang Y; Wilson CG; Renslo AR
    Comb Chem High Throughput Screen; 2014 May; 17(4):333-42. PubMed ID: 24661212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening Library Design.
    Ashenden SK
    Methods Enzymol; 2018; 610():73-96. PubMed ID: 30390806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advancing precision medicine with personalized drug screening.
    Gorshkov K; Chen CZ; Marshall RE; Mihatov N; Choi Y; Nguyen DT; Southall N; Chen KG; Park JK; Zheng W
    Drug Discov Today; 2019 Jan; 24(1):272-278. PubMed ID: 30125678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA-encoded chemical libraries: advancing beyond conventional small-molecule libraries.
    Franzini RM; Neri D; Scheuermann J
    Acc Chem Res; 2014 Apr; 47(4):1247-55. PubMed ID: 24673190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computational and experimental advances in drug repositioning for accelerated therapeutic stratification.
    Shameer K; Readhead B; Dudley JT
    Curr Top Med Chem; 2015; 15(1):5-20. PubMed ID: 25579574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational drug repositioning for rare diseases in the era of precision medicine.
    Delavan B; Roberts R; Huang R; Bao W; Tong W; Liu Z
    Drug Discov Today; 2018 Feb; 23(2):382-394. PubMed ID: 29055182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The University of New Mexico Center for Molecular Discovery.
    Edwards BS; Gouveia K; Oprea TI; Sklar LA
    Comb Chem High Throughput Screen; 2014 Mar; 17(3):256-65. PubMed ID: 24409953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetic cell-based morphological screening: prediction of mechanism of compound action and off-target effects.
    Abassi YA; Xi B; Zhang W; Ye P; Kirstein SL; Gaylord MR; Feinstein SC; Wang X; Xu X
    Chem Biol; 2009 Jul; 16(7):712-23. PubMed ID: 19635408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Big pharma screening collections: more of the same or unique libraries? The AstraZeneca-Bayer Pharma AG case.
    Kogej T; Blomberg N; Greasley PJ; Mundt S; Vainio MJ; Schamberger J; Schmidt G; Hüser J
    Drug Discov Today; 2013 Oct; 18(19-20):1014-24. PubMed ID: 23127858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PAIN(S) relievers for medicinal chemists: how computational methods can assist in hit evaluation.
    Stork C; Kirchmair J
    Future Med Chem; 2018 Jul; 10(13):1533-1535. PubMed ID: 29956552
    [No Abstract]   [Full Text] [Related]  

  • 13. Chemical screening in zebrafish for novel biological and therapeutic discovery.
    Tan JL; Zon LI
    Methods Cell Biol; 2011; 105():493-516. PubMed ID: 21951544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hit triage using efficiency indices after screening of compound libraries in drug discovery.
    Reitz AB; Smith GR; Tounge BA; Reynolds CH
    Curr Top Med Chem; 2009; 9(18):1718-24. PubMed ID: 19929837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-content analysis of kinase activity in cells.
    Gasparri F; Sola F; Bandiera T; Moll J; Galvani A
    Comb Chem High Throughput Screen; 2008 Aug; 11(7):523-36. PubMed ID: 18694389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic assays for chemical biology and drug discovery.
    Gul S
    Clin Epigenetics; 2017; 9():41. PubMed ID: 28439316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A High-Throughput Screening Approach To Repurpose FDA-Approved Drugs for Bactericidal Applications against Staphylococcus aureus Small-Colony Variants.
    Trombetta RP; Dunman PM; Schwarz EM; Kates SL; Awad HA
    mSphere; 2018 Oct; 3(5):. PubMed ID: 30381352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design of screening collections for successful fragment-based lead discovery.
    Na J; Hu Q
    Methods Mol Biol; 2011; 685():219-40. PubMed ID: 20981526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of academic institutions in the development of drugs for rare and neglected diseases.
    Coles LD; Cloyd JC
    Clin Pharmacol Ther; 2012 Aug; 92(2):193-202. PubMed ID: 22760003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bringing RNA into the fold: Small molecules find new targets in RNA to combat disease.
    Chakradhar S
    Nat Med; 2017 May; 23(5):532-534. PubMed ID: 28475574
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.